NIH-funded research R01 grant

How Hormones Change with Age to Affect Ovarian Function

Official title: Understanding The Role Of FSHR Oligomerization And Trafficking In Transducing Age-dependent Changes In FSH Glycoforms

Funded at King's College London · NIH-11172403 · Data updated 2026-11-12

This project explores how different forms of a hormone called FSH affect the ovaries as women get older, aiming to find new ways to support ovarian health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKing's College London
NIH-funded
Lab location1 site (London, United Kingdom)
Project startAugust 19, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$352,847
NIH project number5R01HD113570-02
Project IDNIH-11172403 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is relevant to women experiencing or approaching ovarian aging and its associated health changes.

Less likely to help

Patients not experiencing ovarian aging or related conditions may not directly benefit from this specific research focus.

What this research studies

As women age, their ovaries naturally change, which can lead to health issues like osteoporosis. Currently, there are no treatments to prevent or delay this process, highlighting a need for new approaches to extend ovarian lifespan. This project looks at follicle stimulating hormone (FSH), which comes in different forms that have distinct effects on the ovaries. We know that the less potent form of FSH increases around menopause, coinciding with ovaries becoming less responsive to FSH. This research aims to uncover how these different FSH forms influence ovarian function during aging.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for delaying or preventing ovarian aging, potentially improving women's quality of life and reducing health burdens.

How similar studies have gone: Age-related changes in human pituitary extracts have been reported, showing shifts in FSH forms, but the specific mechanisms explored here are largely unknown.

Where this research is happening

  • King's College London
    London, United Kingdom
    Active

Researchers

  • Principal investigator: Jonas, Kim Carol — King's College London
  • Study coordinator: Jonas, Kim Carol

Related research

Other NIH-funded projects on the same topics.

  • Understanding how FSH receptor teamwork changes with age to affect ovarian aging

    A study from King's College London will explore how different forms of the hormone FSH interact with its receptor as women age, to see if this affects ovarian aging and related health risks.

    NIH research King's College London · London, United Kingdom · NIH-11377552

  • Investigating cancer disparities in Black patients through genetic and environmental analysis

    This study is looking into why prostate, breast, and pancreatic cancers tend to be more aggressive and happen earlier in Black patients, especially in West Africa, by exploring different factors like genetics and environment, and it aims to gather important information to help improve cancer care for these communities.

    NIH research King's College London · London, United Kingdom · NIH-11045099

  • Understanding and preventing early-onset colorectal cancer

    This study is looking at what causes colorectal cancer in people under 50, focusing on how biology, environment, and lifestyle choices work together, so we can find better ways to prevent this disease.

    NIH research King's College London · London, United Kingdom · NIH-11043055

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.